Yazan Abou-Ismail,
MD
Languages Spoken: Arabic, English
Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Assistant Professor of Medicine at the Division of Hematology and Hematologic Malignancies. He specializes in treating non-malignant hematologic disorders, with special clinical interest in disorders of hemostasis and thrombosis, in which he has authored multiple peer-reviewed publications. Dr. Abou-Ismail earned his medical degree from Weill Cornell Medicine in Doha, Qatar in 2014, and then completed three years of Internal Medicine residency training at Rochester General Hospital in Rochester, New York. Afterwards, he completed three years of Hematology and Oncology fellowship training at Case Western Reserve University, in Cleveland, OH, where he was the recipient of the 2018 Harris Foundation award for hematology fellows. Dr. Abou-Ismail's research interests include von Willebrand disease as well as immune-mediated disorders of hemostasis and thrombosis, such as thrombotic thrombocytopenic purpura and acquired hemophilia
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Hematology) |
Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Assistant Professor of Medicine at the Division of Hematology and Hematologic Malignancies. He specializes in treating non-malignant hematologic disorders, with special clinical interest in disorders of hemostasis and thrombosis, in which he has authored multiple peer-reviewed publications. Dr. Abou-Ismail earned his medical degree from Weill Cornell Medicine in Doha, Qatar in 2014, and then completed three years of Internal Medicine residency training at Rochester General Hospital in Rochester, New York. Afterwards, he completed three years of Hematology and Oncology fellowship training at Case Western Reserve University, in Cleveland, OH, where he was the recipient of the 2018 Harris Foundation award for hematology fellows. Dr. Abou-Ismail's research interests include von Willebrand disease as well as immune-mediated disorders of hemostasis and thrombosis, such as thrombotic thrombocytopenic purpura and acquired hemophilia
Academic Locations
Huntsman Cancer Hospital
801-585-3229
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Hematology) |
Education History
| Fellowship | Case Western Reserve University Hematology & Oncology Fellow |
| Residency | Rochester General Hospital Internal Medicine Resident |
| Professional Medical | Weill Cornell Medical College in Qatar Medicine M.D. |
| Doctoral Training | Weill Cornell Medical College in Qatar Premedical Program |
Selected Publications - Journal Articles
Journal Article
- Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L (2020). History of drug use in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant, 56(3), 581-585.
- Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY (2021). Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management. Res Pract Thromb Haemost, 5(2), 356-365.
- Abou-Ismail MY, Arafah Y, Fu P, Cao S, Schmaier AH, Nayak L (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne), 7, 588526.
- Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020). The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res, 194, 101-115.
- Abou-Ismail MY, Citla Sridhar D, Nayak L (2020). Estrogen and thrombosis: A bench to bedside review. Thromb Res, 192, 40-51.
- Abou-Ismail MY, Vuyyala S, Prunty J, Schmaier AH, Nayak L (2020). Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors. Haemophilia, 26(4), 601-606.
- Citla Sridhar D, Abou-Ismail MY, Ahuja SP (2020). Central venous catheter-related thrombosis in children and adults. Thromb Res, 187, 103-112.
- Abou-Ismail MY, Ogunbayo GO, Secic M, Kouides PA (2017). Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study. Am J Hematol, 93(2), 232-237.
Letter
- Abou-Ismail MY, Moser KA, Smock KJ, Lim MY (2021). Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. [Letter to the editor]. Am J Hematol, 96(9), E346-E349.
- Lim MY, Abou-Ismail MY (2021). Left atrial appendage occlusion for management of atrial fibrillation in persons with hemophilia. [Letter to the editor]. Thromb Res, 206, 9-13.